URSOFERRAN®-100 200

1 ml contains 100 or 200 mg of iron (Fe3+) in the form of iron (III) - dextrane-heptonic acid

Pharmacological properties

The iron (III)-dextrane-heptonic acid complex gradually releases Fe3+, which ensures long-lasting effect of the drug on the organism after the parenteral administration of URSOFERRAN®. URSOFERRAN® stimulates erythropoiesis by the active inclusion of iron in hemoglobin and tissue enzymes (cytochromes, cytochrome oxydase, peroxydase, etc), increases immunity.

Indications

- Prevention and treatment of iron deficiency anemia in piglets and minks.

Dosage

The drug is administered on the third or fourth day of life by a single deep intramuscular injection in the neck or upper tight area at the dose of 1.5–2.0 ml of FERZAX®-100 or 0.75 – 1.0 ml of URSOFERRAN®-200 per animal for treatment of piglets. The drug is administered once by a subcutaneous or intramuscular injection at the dose of 0.3 ml of URSOFERRAN®-100 or 0.15 ml of URSOFERRAN®-200 per animal for treatment of female minks during cub feeding in spring. The drug is administered once by a subcutaneous or intramuscular injection in the dose of 0.2 ml of URSOFERRAN®-100 or 0.1 ml of URSOFERRAN®-200 per animal for treatment of mink cubs aged 6 to 12 weeks.

Come back
Наверх